Abstract:Objective:
After congenital heart surgery, some patients may need long-term mechanical ventilation because of chronic respiratory failure. In this study, we analysed outcomes of the patients who need tracheostomy and home mechanical ventilation.
Methods:
Amongst 1343 patients who underwent congenital heart surgery between January, 2014 and June, 2018, 45 needed tracheostomy and HMV. The median age of these patients was 6.4 months (12 days–6.5 years). Nineteen patients underwent palliatio… Show more
“…The high mortality to current follow-up and in-hospital mortality in our study are striking, though overall consistent with existing literature for pediatric patients with cardiac disease requiring tracheostomy (3–5, 15–23). In-hospital mortality for our cohort is 10-fold higher than in-hospital mortality for all CICU patients during the study period and substantially higher than reported mortality in general pediatric patients with tracheostomy (2, 6, 13, 33–35).…”
Section: Discussionsupporting
confidence: 90%
“…The key finding of our study was an association between a longer duration of pre-tracheostomy PPV and the hazard of mortality in children with cardiac disease when controlling for other factors. Seven prior studies have described tracheostomy timing relative to total duration of ventilation in pediatric patients including those with congenital heart disease (CHD) (4, 9, 16, 17, 19, 20, 22), but only two specifically compared outcomes based on timing of tracheostomy in children with heart disease (4, 22). A single-institution study of 17 cardiac patients (22) and a multicenter cohort of 126 patients with hypoplastic left heart syndrome (HLHS) (4) both failed to identify an association between duration of ventilation pre-tracheostomy and survival.…”
Section: Discussionmentioning
confidence: 99%
“…The frequency of tracheostomy in children with cardiac disease has, however, increased in recent years (2,4,5). Indications for tracheostomy for children with cardiac disease are often multifactorial, and long-term survival is as low as 50% (15)(16)(17)(18)(19)(20)(21)(22). Although studies describe the epidemiology of pediatric patients with cardiac disease undergoing tracheostomy, most are restricted to single-center studies with small cohorts, limited outcomes, specific cardiac diagnoses, or a few multicenter studies that lack longitudinal follow-up data (3)(4)(5)(15)(16)(17)(18)(19)(20)(21)(22)(23).…”
Section: E557mentioning
confidence: 99%
“…Indications for tracheostomy for children with cardiac disease are often multifactorial, and long-term survival is as low as 50% (15)(16)(17)(18)(19)(20)(21)(22). Although studies describe the epidemiology of pediatric patients with cardiac disease undergoing tracheostomy, most are restricted to single-center studies with small cohorts, limited outcomes, specific cardiac diagnoses, or a few multicenter studies that lack longitudinal follow-up data (3)(4)(5)(15)(16)(17)(18)(19)(20)(21)(22)(23). Although heterogeneous pediatric cohorts including cardiac patients show later tracheostomy to be associated with worse outcomes (9,13), two cardiac-specific cohorts did not identify an association between the timing of tracheostomy and mortality (4,22).…”
Section: E557mentioning
confidence: 99%
“…Tracheostomy use in pediatric patients with cardiac disease is unique from other pediatric conditions such as respiratory failure, upper airway obstruction (UAO), and neurologic injuries/trauma, with relatively lower use, higher mortality, and wide variation in timing (2–4, 9, 14–20). Differences in use are likely attributable to concerns for infectious risk or cardiopulmonary interactions, staged cardiac surgical procedures that might obviate the need for tracheostomy or hope for recovery (7).…”
OBJECTIVES:
To describe associations between the timing of tracheostomy and patient characteristics or outcomes in the cardiac ICU (CICU).
DESIGN:
Single-institution retrospective cohort study.
SETTING:
Freestanding academic children’s hospital.
PATIENTS:
CICU patients with tracheostomy placed between July 1, 2011, and July 1, 2020.
INTERVENTIONS:
We compared patient characteristics and outcomes between early and late tracheostomy based on the duration of positive pressure ventilation (PPV) before tracheostomy placement, fitting a receiver operating characteristic curve for current survival to define a cutoff.
MEASUREMENTS AND MAIN RESULTS:
Sixty-one patients underwent tracheostomy placement (0.5% of CICU admissions). Median age was 7.8 months. Eighteen patients (30%) had single ventricle physiology and 13 patients (21%) had pulmonary vein stenosis (PVS). Primary indications for tracheostomy were pulmonary/lower airway (41%), upper airway obstruction (UAO) (31%), cardiac (15%), neuromuscular (4%), or neurologic (4%). In-hospital mortality was 26% with 41% survival at the current follow-up (median 7.8 [interquartile range, IQR 2.6–30.0] mo). Late tracheostomy was defined as greater than or equal to 7 weeks of PPV which was equivalent to the median PPV duration pre-tracheostomy. Patients with late tracheostomy were more likely to be younger, have single ventricle physiology, and have greater respiratory severity. Patients with early tracheostomy were more likely to have UAO or genetic comorbidities. In multivariable analysis, late tracheostomy was associated with 4.2 times greater mortality (95% CI, 1.9–9.0). PVS was associated with higher mortality (adjusted hazard ratio [HR] 5.2; 95% CI, 2.5–10.9). UAO was associated with lower mortality (adjusted HR 0.2; 95% CI, 0.1–0.5). Late tracheostomy was also associated with greater cumulative opioid exposure.
CONCLUSIONS:
CICU patients who underwent tracheostomy had high in-hospital and longer-term mortality rates. Tracheostomy timing decisions are influenced by indication, disease, genetic comorbidities, illness severity, and age. Earlier tracheostomy was associated with lower sedative use and improved adjusted survival. Tracheostomy placement is a complex decision demanding individualized consideration of risk-benefit profiles and thoughtful family counseling.
“…The high mortality to current follow-up and in-hospital mortality in our study are striking, though overall consistent with existing literature for pediatric patients with cardiac disease requiring tracheostomy (3–5, 15–23). In-hospital mortality for our cohort is 10-fold higher than in-hospital mortality for all CICU patients during the study period and substantially higher than reported mortality in general pediatric patients with tracheostomy (2, 6, 13, 33–35).…”
Section: Discussionsupporting
confidence: 90%
“…The key finding of our study was an association between a longer duration of pre-tracheostomy PPV and the hazard of mortality in children with cardiac disease when controlling for other factors. Seven prior studies have described tracheostomy timing relative to total duration of ventilation in pediatric patients including those with congenital heart disease (CHD) (4, 9, 16, 17, 19, 20, 22), but only two specifically compared outcomes based on timing of tracheostomy in children with heart disease (4, 22). A single-institution study of 17 cardiac patients (22) and a multicenter cohort of 126 patients with hypoplastic left heart syndrome (HLHS) (4) both failed to identify an association between duration of ventilation pre-tracheostomy and survival.…”
Section: Discussionmentioning
confidence: 99%
“…The frequency of tracheostomy in children with cardiac disease has, however, increased in recent years (2,4,5). Indications for tracheostomy for children with cardiac disease are often multifactorial, and long-term survival is as low as 50% (15)(16)(17)(18)(19)(20)(21)(22). Although studies describe the epidemiology of pediatric patients with cardiac disease undergoing tracheostomy, most are restricted to single-center studies with small cohorts, limited outcomes, specific cardiac diagnoses, or a few multicenter studies that lack longitudinal follow-up data (3)(4)(5)(15)(16)(17)(18)(19)(20)(21)(22)(23).…”
Section: E557mentioning
confidence: 99%
“…Indications for tracheostomy for children with cardiac disease are often multifactorial, and long-term survival is as low as 50% (15)(16)(17)(18)(19)(20)(21)(22). Although studies describe the epidemiology of pediatric patients with cardiac disease undergoing tracheostomy, most are restricted to single-center studies with small cohorts, limited outcomes, specific cardiac diagnoses, or a few multicenter studies that lack longitudinal follow-up data (3)(4)(5)(15)(16)(17)(18)(19)(20)(21)(22)(23). Although heterogeneous pediatric cohorts including cardiac patients show later tracheostomy to be associated with worse outcomes (9,13), two cardiac-specific cohorts did not identify an association between the timing of tracheostomy and mortality (4,22).…”
Section: E557mentioning
confidence: 99%
“…Tracheostomy use in pediatric patients with cardiac disease is unique from other pediatric conditions such as respiratory failure, upper airway obstruction (UAO), and neurologic injuries/trauma, with relatively lower use, higher mortality, and wide variation in timing (2–4, 9, 14–20). Differences in use are likely attributable to concerns for infectious risk or cardiopulmonary interactions, staged cardiac surgical procedures that might obviate the need for tracheostomy or hope for recovery (7).…”
OBJECTIVES:
To describe associations between the timing of tracheostomy and patient characteristics or outcomes in the cardiac ICU (CICU).
DESIGN:
Single-institution retrospective cohort study.
SETTING:
Freestanding academic children’s hospital.
PATIENTS:
CICU patients with tracheostomy placed between July 1, 2011, and July 1, 2020.
INTERVENTIONS:
We compared patient characteristics and outcomes between early and late tracheostomy based on the duration of positive pressure ventilation (PPV) before tracheostomy placement, fitting a receiver operating characteristic curve for current survival to define a cutoff.
MEASUREMENTS AND MAIN RESULTS:
Sixty-one patients underwent tracheostomy placement (0.5% of CICU admissions). Median age was 7.8 months. Eighteen patients (30%) had single ventricle physiology and 13 patients (21%) had pulmonary vein stenosis (PVS). Primary indications for tracheostomy were pulmonary/lower airway (41%), upper airway obstruction (UAO) (31%), cardiac (15%), neuromuscular (4%), or neurologic (4%). In-hospital mortality was 26% with 41% survival at the current follow-up (median 7.8 [interquartile range, IQR 2.6–30.0] mo). Late tracheostomy was defined as greater than or equal to 7 weeks of PPV which was equivalent to the median PPV duration pre-tracheostomy. Patients with late tracheostomy were more likely to be younger, have single ventricle physiology, and have greater respiratory severity. Patients with early tracheostomy were more likely to have UAO or genetic comorbidities. In multivariable analysis, late tracheostomy was associated with 4.2 times greater mortality (95% CI, 1.9–9.0). PVS was associated with higher mortality (adjusted hazard ratio [HR] 5.2; 95% CI, 2.5–10.9). UAO was associated with lower mortality (adjusted HR 0.2; 95% CI, 0.1–0.5). Late tracheostomy was also associated with greater cumulative opioid exposure.
CONCLUSIONS:
CICU patients who underwent tracheostomy had high in-hospital and longer-term mortality rates. Tracheostomy timing decisions are influenced by indication, disease, genetic comorbidities, illness severity, and age. Earlier tracheostomy was associated with lower sedative use and improved adjusted survival. Tracheostomy placement is a complex decision demanding individualized consideration of risk-benefit profiles and thoughtful family counseling.
Objectives: This study aimed to review the characteristics and outcomes of children with congenital heart disease requiring tracheostomy after cardiac surgery. Methods: Medical records of 65 out of 2814 consecutive patients who required tracheostomy after congenital heart surgery between March 2018 and March 2023 were retrospectively reviewed. Outcomes such as hospital survival, long-term survival, and weaning from positive pressure ventilation were elucidated. Results: During the 5-year period, a total of 65 of 2814 (2.3%) patients required tracheostomy in the pediatric intensive care unit after surgery. The median patient age was 5 (range, 0.6-24) months and the median weight was 4.3 kg (range, 3.3-11). A total of 23 (35.5%) patients demonstrated a single-ventricle physiology while 42 (64.5%) patients manifested with biventricle physiology. A total of 11 (16.9%) patients were syndromic, including Down syndrome in 6 patients, Di George syndrome in 3 patients, and Williams syndrome in 2 patients. In the whole cohort (65 patients), the mean time to tracheostomy from cardiac surgery was 30±16 days. In-hospital mortality was noted in 20 of the patients (30.8%) who underwent tracheostomy. Twenty-six patients (40%) were decannulated and discharged without a tracheostomy, and 14 patients (22%) were discharged with a tracheostomy cannula and home-type mechanical ventilator (HMV).
Conclusion:Tracheostomy is a viable option for pediatric patients with prolonged mechanical ventilation after heart surgery for congenital heart disease. It creates an opportunity to discharge patients on HMV, if repeated attempts of extubation and decannulation fail, albeit with potential risks.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.